1 0

    FDA ANDA 216937, Approval Letter for Nimodipine Oral Solution

    FDA ANDA 216937, Approval Letter for Nimodipine Oral Solution

    $89.00 USD
    $89.00 USD
    Sale Sold out

    Contents: ANDA approval letter for ANDA 216937, Nimodipine Oral Solution, 3 mg/ml held by Annora Pharma which was approved July 9, 2024.

    Drug Name: NIMODIPINE
    Active Ingredients: NIMODIPINE
    Strength: 3MG/ML
    Dosage Form / Route: SOLUTION;ORAL
    Action Date: 07/09/2024
    Marketing Status: Prescription
    • Status: Pending Fast-Track Request
    • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

    NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

    View full details